Di Liang

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Pulmonary Fibrosis

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Guangrui Chen, Jian Li, Huimeng Liu, Huiyu Zhou, Mingqiu Liu, Di Liang, Zhiyun Meng, Hui Gan, Zhuona Wu, Xiaoxia Zhu, Peng Han, Taoyun Liu, Ruolan Gu, Shuchen Liu, Guifang Dou
Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation. Molecules (Basel, Switzerland) 28 (2) (2023)
Yutong Liang, Biqiong Chen, Di Liang, Xiaoxiao Quan, Ruolan Gu, Zhiyun Meng, Hui Gan, Zhuona Wu, Yunbo Sun, Shuchen Liu, Guifang Dou
Pharmacological Effects of Astragaloside IV: A Review. Molecules (Basel, Switzerland) 28 (16) (2023)
Guangrui Chen, Jian Li, Huimeng Liu, Huiyu Zhou, Mingqiu Liu, Di Liang, Zhiyun Meng, Hui Gan, Zhuona Wu, Xiaoxia Zhu, Peng Han, Taoyun Liu, Ruolan Gu, Shuchen Liu, Guifang Dou
Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation. Molecules (Basel, Switzerland) 28 (2) (2023)
Di Liang, Wanmei Wang, Guangrui Chen, Jian Li, Guifang Dou, Hui Gan, Peng Han, Lina Du, Ruolan Gu
Cepharanthine Dry Powder Inhaler for the Treatment of Acute Lung Injury. Molecules (Basel, Switzerland) 28 (11) (2023)
Guangrui Chen, Jian Li, Huimeng Liu, Huiyu Zhou, Mingqiu Liu, Di Liang, Zhiyun Meng, Hui Gan, Zhuona Wu, Xiaoxia Zhu, Peng Han, Taoyun Liu, Ruolan Gu, Shuchen Liu, Guifang Dou
Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation. Molecules (Basel, Switzerland) 28 (2) (2023)
Guangrui Chen, Jian Li, Huimeng Liu, Huiyu Zhou, Mingqiu Liu, Di Liang, Zhiyun Meng, Hui Gan, Zhuona Wu, Xiaoxia Zhu, Peng Han, Taoyun Liu, Ruolan Gu, Shuchen Liu, Guifang Dou
Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation. Molecules (Basel, Switzerland) 28 (2) (2023)
Guangrui Chen, Jian Li, Huimeng Liu, Huiyu Zhou, Mingqiu Liu, Di Liang, Zhiyun Meng, Hui Gan, Zhuona Wu, Xiaoxia Zhu, Peng Han, Taoyun Liu, Ruolan Gu, Shuchen Liu, Guifang Dou
Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation. Molecules (Basel, Switzerland) 28 (2) (2023)
Di Liang, Qi Li, Lina Du, Guifang Dou
Pharmacological Effects and Clinical Prospects of Cepharanthine. Molecules (Basel, Switzerland) 27 (24) (2022)
Di Liang, Qi Li, Lina Du, Guifang Dou
Pharmacological Effects and Clinical Prospects of Cepharanthine. Molecules (Basel, Switzerland) 27 (24) (2022)
Di Liang, Qi Li, Lina Du, Guifang Dou
Pharmacological Effects and Clinical Prospects of Cepharanthine. Molecules (Basel, Switzerland) 27 (24) (2022)
Di Liang, Qi Li, Lina Du, Guifang Dou
Pharmacological Effects and Clinical Prospects of Cepharanthine. Molecules (Basel, Switzerland) 27 (24) (2022)